Global Markets for Enzyme Inhibitors

Published - Jun 2012| Analyst - Shalini Shahani Dewan| Code - BIO057B
Market Research Report Single User License: $3325

Report Highlights

The global market for enzyme inhibitors was valued at $104.4 billion in 2010 and reached nearly $104.6 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 4% and reach nearly $127.4 billion by 2016.

Report Scope

The scope of this study encompasses enzyme inhibitors in the pharmaceutical and biotechnology industry.  BCC Research analyzes each market and its applications, regulatory environment, technology involved, market projections and market share.  Technological issues include the latest trends and developments.  Emerging markets for enzyme inhibitors include countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

Analyst Credentials

The study has been carried out by a team of professionals in the biotechnology industry.  The project manager for this project is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.  Dewan was awarded a Gold Medal by the prime minister of India for her work and has worked with top companies in India and in the U.S.  Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant for this project is Dr. Kapil A. Setia, who has a doctorate in life sciences.  She has a number of research publications in her credit, including her thesis on “Studies on Phenotypic Variation, Clonal Propagation and Phyto-chemistry of Tinospora cordifolia (Willd.),” which was given an award of excellence. 

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price
Full Report: Global Markets for Enzyme Inhibitors 315 $3325
Chapter- 1: INTRODUCTION 4
Chapter- 2: SUMMARY 3 $250
Chapter- 3: OVERVIEW 22 $348
Chapter- 4: REGULATORY ASPECTS 8 $127
Chapter- 5: MARKET LEADERS AND THEIR PRODUCTS FOR ENZYME INHIBITORS 6 $95
Chapter- 6: NEW DEVELOPMENTS 15 $238
Chapter- 7: GLOBAL MARKETS 60 $950
Chapter- 8: MARKETS IN THE UNITED STATES 54 $855
Chapter- 9: MARKETS IN EUROPE 52 $823
Chapter- 10: EMERGING MARKETS 49 $776
Chapter- 11: PATENT ANALYSIS 10 $158
Chapter- 12: CURRENT SITUATION 6 $95
Chapter- 13: COMPANY PROFILES 24 $380
Chapter- 14: APPENDIX—ABBREVIATIONS 2 $32
List of Tables
List of Figures
Download Table of Contents
RELATED REPORTS
Share This Report